References
- Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11:889-96; PMID:20856220; http://dx.doi.org/10.1038/ni.1937
- De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013; 23:277-86; PMID:23518347; http://dx.doi.org/10.1016/j.ccr.2013.02.013
- Lewis CE, Harney AS, Pollard JW. The multifaceted role of perivascular macrophages in tumors. Cancer Cell 2016; 30:18-25; PMID:27411586; http://dx.doi.org/10.1016/j.ccell.2016.05.017
- Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, et al. miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep 2012; 1:141-54; PMID:22832163; http://dx.doi.org/10.1016/j.celrep.2011.12.005
- Baer C, Squadrito ML, Laoui D, Thompson D, Hansen SK, Kiialainen A, Hoves S, Ries CH, Ooi CH, De Palma M. Suppression of microRNA activity amplifies IFN-gamma-induced macrophage activation and promotes anti-tumour immunity. Nat Cell Biol 2016; 18:790-802; PMID:27295554; http://dx.doi.org/10.1038/ncb3371
- Su JL, Chen PS, Johansson G, Kuo ML. Function and regulation of let-7 family microRNAs. MicroRNA 2012; 1:34-9; PMID:25048088; http://dx.doi.org/10.2174/2211536611201010034
- De Palma M, Hanahan D. The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities. Mol Oncol 2012; 6:111-27; PMID:22360993; http://dx.doi.org/10.1016/j.molonc.2012.01.011